New weight loss pill shows promise in early trial
Disease control
Completed
This study tested an experimental oral medication called TERN-601 in 167 adults with overweight or obesity. The goal was to see if it helps with weight loss over 12 weeks compared to a placebo. Participants did not have diabetes and had a stable weight before starting. The study …
Phase: PHASE2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC